Need Help? Chat Now With a Live Representative!

Resources Library

Xtalks Webinar: Conducting Early Phase Clinical Trials in the US for APAC Sponsors

Xtalks Webinar: Conducting Early Phase Clinical Trials in the US for APAC Sponsors

On Wednesday, May 11, 2022 at 8pm EDT (Thursday, May 12 at 8am China Standard Time), ARG and Xtalks will […]

April 6, 2022
The ARG Oncology Academy: “Committed to Furthering Research”

The ARG Oncology Academy: “Committed to Furthering Research”

The ARG Oncology Academy is a training and development program that provides staff with the skills and tools necessary to […]

March 2, 2022
Q & A with Dr. Ignazio Di Giovanna: Implementing EU 536/2014

Q & A with Dr. Ignazio Di Giovanna: Implementing EU 536/2014

In the EU,  the date of applicability for Regulation 536/ 2014 was January 31, 2022. We asked Dr. Ignazio Di […]

February 17, 2022
ARG One of 16 Companies Selected to Participate in Virginia Trade Program

ARG One of 16 Companies Selected to Participate in Virginia Trade Program

The Virginia Economic Development Partnership (VEDP) recently announced in a press release the “acceptance of 16 companies into its two-year […]

January 19, 2022
Webinar: RBQM 101: Getting Started with Risk-Based Quality Management

Webinar: RBQM 101: Getting Started with Risk-Based Quality Management

In this free webinar, the featured speakers will discuss the importance of making risk-based quality management (RBQM) accessible. It will […]

October 18, 2021
ARG Collaborating with Cytokinetics on the COURAGE-ALS Trial of Reldesemtiv

ARG Collaborating with Cytokinetics on the COURAGE-ALS Trial of Reldesemtiv

Our partner Cytokinetics, Incorporated announced August 2, 2021 that COURAGE-ALS, a Phase 3 clinical trial of Reldesemtiv in patients with ALS, is open to enrollment.

August 11, 2021
GO TO TOP